Showing posts with label Health science. Show all posts
Showing posts with label Health science. Show all posts

Sunday, March 15, 2009

Obama's administration is putting $19 billion toward "Health IT,"


Obama's administration is putting $19 billion toward electronic health record systems to get better treatment and inferior costs.
When Saver begins to examine his patient, however, the 56-year-old physician does something that four out of five doctors in America do not: He pulls out a computer.
The little black Toshiba, its edges worn to the bare metal, gets more use than the stethoscope and has become key to the care Saver gives his patients -- organizing medical histories, test results, prescriptions and other data that were once a jumble of paper records.

Saver's laptop, and the system behind it, put him on the cutting edge of what President Obama and many experts say is a critical step to improving the nation's healthcare system while also reining in cost.It is known as "Health IT," an idea that promises to use information technology to cut medical errors, avoid unnecessary tests and procedures and identify better treatments.

The New York system, which links more than 800 providers, also allows public health officials to quickly tap patient data to track disease outbreaks and send doctors up-to-the-minute advisories.

"There are just huge opportunities here," said Farzad Mostashari, an assistant health commissioner in New York
.

Sunday, August 26, 2007

A new research centre will focus on using human DNA to construct nanomolecules that can be used in battling disease



The University of Aarhus celebrated the opening of its new Centre for DNA Nanotechnology on Friday as a giant leap into the future of fighting disease using the building blocks of the human body.
Founded through a grant from the Danish National Research Foundation, the CDNA will develop new methods within nanotechnology for better treatment and diagnosis of diseases linked to DNA.
Researchers now work with materials so small that they can be difficult to work with using even the most powerful microscopes and equipment. CDNA researchers will focus specifically on using and developing nanotechnology with the most intricate, high-tech equipment available to manipulate the minute materials and create self-regulating units out of them.
‘We will then be able to produce medicines that only work in the precise areas of a person’s disease,’ Kurt Vesterager Gothelf, chemistry professor at CDNA, told Nyhedsavisen newspaper. ‘For example, we can make an anti-cancer drug that only attacks the cancer cells. It will result in far fewer side effects than traditional chemotherapy.’
These self-regulating molecules will be so specialised and so advanced that they will replace many of the bulky existing regulating devices, such as pacemakers.
In addition, nanotechnology can pave the way for substances which can locate bacteria in food or uncover dangerous substances during airport security checks.
The CDNA research team consists of three scientists from the University of Aarhus and two from the United States. The quality of the team is second to none, according to the university’s assistant dean, Mette Bock.
‘The new research centre and its team put us up in the international elite and give us many exciting development perspectives.’

More News.

DNA acts like a “piston”

Biophysicists have built a DNA nanomolecular device that expands and contracts with the addition of “fuel” DNA. Patrizia Alberti and Jean-Louis Mergny at the Muséum National d’Histoire Naturelle in Paris constructed the piston-like device using a single strand of nucleotides. They believe that it could be used as a structural component in nanomolecular machines (P Alberti and J-L Mergny 2003 Proc. Nat. Acad. Sci. to be published).
DNA is often called the “building block of life”. It consists of two linear strands wound into a double helix with one of four different “bases” attached to every sugar group along the strands. DNA is an attractive component for use in molecular machines because it can recognize specific base sequences. It self-assembles easily and complex molecular structures can be made from simple double helices. In addition, DNA can change its shape, which further expands the number of nanostructures possible.
Alberti and Mergny used an unusual “quadruplex” DNA structure, which contains four strands with twenty-one bases, folded in a special way. The structure is made to unfold by adding a fuel DNA strand, creating a “duplex” structure that resembles the more conventional double helix. To re-fold the duplex, the researchers add an “anti-fuel”, which combines with the fuel to form a waste product. The folding-unfolding cycle takes only a few seconds and fluorescence resonance energy-transfer spectroscopy shows that the expansion and contraction occurs over a distance of 5 to 6 nanometres.
The device oscillates between two well-defined states and can be compared to the movement of a piston in a cylinder, the researchers say. “This new type of extension-contraction movement ties in well with work by other groups who observe rotation and scissor-like opening and closing,” Mergny told PhysicsWeb. “From a nanotechnology point of view, it is possible to finely control the structure by the addition of strands with specific sequences.”
The sequence of bases along the chain chosen by the researchers is important biologically and the team now hopes to look at other sequences that exhibit the same type of movement. “We would also like to know if quadruplexes are able to form inside a human cell,” Mergny added.

Friday, August 3, 2007

Taking Avandia? or not?

Now that the FDA has given the green light to allow a popular diabetes drug to stay on the market, many who take Avandia are wondering whether they should be taking it. Avandia is used by people with type two diabetes to control the amount of sugar or glucose the body puts out. And to help the body's insulin work more effectively. Since it went on the market in 1999, it's been used by about 6-million people in this country. But the FDA Advisory panel says there are certain diabetics who should definitely not take the drug. Those people include those who are prone to congestive heart failure or have already been diagnosed with the condition. People who are prone to heart attacks should also not be taking Avandia, according to the FDA's advisors. In addition, people who are long term insulin users have been found to be at higher risk for cardiovascular problems caused by the drug, as have people who are taking nitrates for chest pain or angina. Exactly how these warnings will be issued is still being worked out by the advisory panel, but at this point if you are taking Avandia and have a concern about the drug, the best advice is to talk with your doctor.